New imaging study aims to sharpen radiotherapy for head and neck cancer
NCT ID NCT04612075
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether advanced PET/MR imaging can help doctors personalize radiotherapy for head and neck cancer. Researchers will scan 390 patients before, during, and after treatment to see if imaging details can predict survival and response. The goal is to improve outcomes and reduce side effects by tailoring radiation more precisely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FDG-PET/MRI (diagnostic imaging test)
What this could lead to
If successful, this could lead to more personalized radiotherapy for head and neck cancer, potentially improving survival and reducing side effects.
What could go wrong
This is an observational imaging study, not a treatment trial. It may not directly change patient outcomes, and results may take years to apply in practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St Olavs Hospital, Department of Oncology
RECRUITINGTrondheim, Norway
Contact Email: •••••@•••••
-
University Hospital of North Norway
NOT_YET_RECRUITINGTromsø, Norway